deferoxamine has been researched along with noc 18 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akaike, A; Ibi, M; Kaneko, S; Katsuki, H; Kume, T; Sawada, H; Shimohama, S | 1 |
| Fujita, H; Furihata, M; Inoue, K; Kamada, M; Karashima, T; Kurabayashi, A; Sasaki, J; Shuin, T; Utsumi, K | 1 |
2 other study(ies) available for deferoxamine and noc 18
| Article | Year |
|---|---|
Depletion of intracellular glutathione increases susceptibility to nitric oxide in mesencephalic dopaminergic neurons.
Topics: Animals; Buthionine Sulfoximine; Cells, Cultured; Deferoxamine; Dopamine; Fetus; Glutamic Acid; Glutathione; Mesencephalon; Neurons; Neurotoxins; Nitric Oxide Donors; Nitroso Compounds; Rats | 1999 |
Regulation of 5-aminolevulinic acid-mediated protoporphyrin IX accumulation in human urothelial carcinomas.
Topics: Aminolevulinic Acid; beta-Alanine; Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone; Carcinoma, Transitional Cell; Cell Line, Tumor; Deferoxamine; Ferrochelatase; Flow Cytometry; Humans; Microscopy, Fluorescence; Mitochondria; Nitroso Compounds; Oxidative Phosphorylation; Photosensitizing Agents; Protoporphyrins; Time Factors; Urinary Bladder Neoplasms; Urothelium | 2009 |